Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Availability of Lipid Emulsion to Regional Anesthesia Programs at US Academic Anesthesia Departments

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01880034
Recruitment Status : Completed
First Posted : June 18, 2013
Last Update Posted : May 12, 2017
Sponsor:
Information provided by (Responsible Party):
University of Wisconsin, Madison

Brief Summary:

Significant data exists to suggest that lipid emulsion administration in the setting of local anesthetic toxicity has the potential to be life-saving. Unfortunately, a variety of potential barriers exist to routine lipid emulsion administration for those performing regional anesthesia including drug availability, drug cost and drug location. Inadequate training or lack of established protocols also have the potential to negatively impact patient outcomes. A previous study by Toledo et al (Availability of lipid emulsion in United States obstetric units. Anesth Analg 2013;116:406-408.) evaluated lipid emulsion availability on obstetric units and found that it was nearly universally available.

The Accreditation Council for Graduate Medical Education (ACGME) publishes a list of contact information for each anesthesia institution that engages in resident training. Investigators will contact these institutions by phone or email to obtain contact information for their regional anesthesia program director. In the absence of a program director, investigators will send a survey and consent information via email to the faculty physician most involved in regional anesthesia. Survey completion instructions (survey itself to be completed on Qualtrics Survey Hosting Service) and copy of the study consent form will be attached to the initial contact email. The study consent form will contain a description of the study itself. Survey participants will be allowed time to complete their survey in private at their discretion. Non-responders will receive two follow-up emails at one month intervals.


Condition or disease Intervention/treatment
Local Anesthetic Systemic Toxicity Other: Lipid Emulsion Survey

Layout table for study information
Study Type : Observational
Actual Enrollment : 18 participants
Observational Model: Other
Time Perspective: Other
Official Title: Availability of Lipid Emulsion to Regional Anesthesia Programs at US Academic Anesthesia Departments
Study Start Date : June 2013
Actual Primary Completion Date : December 2014
Actual Study Completion Date : December 2014

Group/Cohort Intervention/treatment
Regional Anesthesia Section Heads
This group will consist of Regional Anesthesia Section Heads at anesthesia residency training programs.
Other: Lipid Emulsion Survey



Primary Outcome Measures :
  1. Is lipid emulsion available at all locations where regional anesthesia is practiced in your institution? [ Time Frame: Two months ]

    Survey options include

    1. Yes, lipid emulsion is available in the room where regional anesthesia is performed.
    2. Yes, lipid emulsion is available in a near-by pharmacy
    3. Yes, lipid emulsion is available in a central pharmacy
    4. No, lipid emulsion is not available in all locations where regional anesthesia is performed


Secondary Outcome Measures :
  1. If lipid emulsion is available to those practicing regional anesthesia at your institution, how long would it take to obtain it? [ Time Frame: Two Months. ]

    Possible responses include:

    • Lipid emulsion is not available at our institution.
    • Less than 10 minutes
    • 10-30 minutes
    • More than 30 minutes



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Regional Anesthesia Section heads at academic anesthesia institutions.
Criteria

Inclusion Criteria:

  • Regional Anesthesia Section heads at academic anesthesia institutions.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01880034


Locations
Layout table for location information
United States, Wisconsin
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison

Layout table for additonal information
Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT01880034     History of Changes
Other Study ID Numbers: 2013-0324
First Posted: June 18, 2013    Key Record Dates
Last Update Posted: May 12, 2017
Last Verified: May 2017
Additional relevant MeSH terms:
Layout table for MeSH terms
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs